Completion of enrollment anticipated within 12 months GALILEO-3 is intended to support the registration of FLT201 in ...

Accessia Health, a national charitable 501(c)(3) patient assistance organization that supports people living with chronic and rare health conditions, announced the opening of two financial assistance ...

Novo Nordisk will conduct a non-exclusive internal evaluation of semaglutide implants prepared by VivaniALAMEDA, Calif., July ...

"ITV Studios is not for sale," Carolyn McCall, boss of U.K. media conglomerate ITV, firmly told Variety three years ago.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...

SCCT2026 brings together clinicians and researchers from around the world to advance the science and practice of ...

Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of ...

Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...

Introduction Tribal people in India face a growing risk of multimorbidity, primarily from cardiovascular diseases (CVD) due to changing lifestyles and unique socio-cultural and political factors. We ...

The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the ...